Products
Preparation registered in Ukraine
Bozhenko N.
Tizalud in myofascial pain dysfunction treatment
In this study effect and safety of Tizalud (tizanidine) produced by “Kyiv Vitamin Factory” in complex treatment of myofascial pain syndrome (MFS) in patients with vertebral pathology were investigated. It was concluded that Tizalud is an effective drug in vertebrogenic MFS treatment; the application of Tizalud reduces the recovery period and prevents unwanted side effects of nonspecific anti-inflammatory drugs because of its gastroprotective effects. Tizalud enhances therapeutic efficacy of dorsalgia treatment regimens. Trends in clinical efficacy of Tizalud allow us to recommend this drug in treatment of vertebrogenic MFS. Its efficacy is prolonged and stabilized by the application of anti-inflammatory, antiedemic, vascular, and vitamin therapy.
Key words: myofascial pain syndrome, dorsalgia, tizanidine, Tizalud.